Reimagining Mental Healthcare in the Age of AI

Maurizio Fava MD moderated a panel with Mill Brown MD, Paul English, Luis Voloch and Sabine Wilhelm PhD on how artificial intelligence could expand mental healthcare in a system that does not have enough clinicians to meet current demand.

The panel drew an important line between access and clinical care. Wilhelm distinguished general-purpose AI systems from tools designed and validated specifically for mental health. A consumer chatbot may be willing to discuss depression, anxiety or obsessive-compulsive disorder without the evidence, safety testing or privacy standards expected of a healthcare product.

Brown brought the clinical operating perspective, English the entrepreneurial one and Voloch the challenge of building and paying for new models of care. Together, they pushed the conversation beyond whether AI can talk to patients and toward whether tools can be validated, reimbursed and integrated responsibly.

Wilhelm also noted that clinicians may increasingly need to ask patients how they use AI. In some cases it can provide useful support. In others, it can reinforce harmful patterns, such as repeatedly seeking reassurance in obsessive-compulsive disorder. The opportunity is significant, but human oversight, clinical evidence and payment will determine whether AI actually improves mental healthcare.